First Amendment of Option and License AgreementOption and License Agreement • March 9th, 2015 • Opexa Therapeutics, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT OF OPTION AND LICENSE AGREEMENT (the “Amendment”) is dated as of March 9, 2015 (the “Amendment Effective Date”) by and between Opexa Therapeutics, Inc., a corporation organized under the laws of Texas having a place of business at 2635 Technology Forest Boulevard, The Woodlands, TX 77381 (“Opexa”), and Ares Trading S.A., a corporation organized under the laws of Switzerland having a place of business at Zone Industrielle de l’Ouriettaz, 1170 Aubonne, Switzerland (“Merck”). Opexa and Merck may be referred to herein as a “Party” or, collectively, as “Parties.”
